**AI驱动的病理学云平台Proscia完成900万美元C+轮融资**

全球领先的数字病理软件供应商Proscia今日宣布,已在C+轮融资中成功筹集900万美元,使得本轮融资的总金额达到4600万美元。这一轮投资由Highline Capital Management和Triangle Peak Partners领投,包括Alpha Intelligence Capital、Scale Venture Partners以及Hitachi Ventures等现有投资者也参与了跟投。

Proscia公司表示,此次筹集的资金将主要用于推动公司的商业扩张,同时加速其在生命科学和诊断实验室领域的人工智能应用的研发。Proscia的AI驱动病理学云平台已经在业界树立了标杆,通过创新技术提升病理检测的效率和准确性,为医疗健康领域带来了革命性的变化。

此次融资的成功,不仅彰显了投资者对Proscia技术实力和市场前景的信心,也为Proscia在病理学数字化领域的持续创新注入了新的动力。随着资金的到位,Proscia有望加速其AI技术的商业化进程,进一步推动全球病理学研究和临床诊断的智能化发展。

英语如下:

**AI-Powered Pathology Platform Proscia Secures $9 Million in C+ Funding Round**

Proscia, a global leader in digital pathology software, has announced that it has raised $9 million in a C+ funding round, bringing the total raised to $46 million. The round was led by Highline Capital Management and Triangle Peak Partners, with participation from existing investors Alpha Intelligence Capital, Scale Venture Partners, and Hitachi Ventures.

The company intends to use the funds to fuel its commercial expansion and accelerate the development of artificial intelligence (AI) applications in the life sciences and diagnostic laboratory sectors. Proscia’s AI-driven pathology cloud platform has set the standard in the industry, enhancing the efficiency and accuracy of pathology testing, thereby revolutionizing the healthcare landscape.

This successful funding round not only underscores investors’ confidence in Proscia’s technological prowess and market potential but also bolsters the company’s ongoing innovation in the digital pathology space. With the new capital, Proscia is poised to expedite the commercialization of its AI technologies, further advancing the智能化 of global pathology research and clinical diagnostics.

【来源】https://venturebeat.com/ai/proscias-46m-series-c-propels-ai-driven-pathology-into-the-mainstream/

Views: 1

发表回复

您的邮箱地址不会被公开。 必填项已用 * 标注